Effect of Medication Co-payment Vouchers on P2Y(12) Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial

IMPORTANCE: Despite guideline recommendations, many patients discontinue P2Y(12) inhibitor therapy earlier than the recommended 1 year after myocardial infarction (MI), and higher-potency P2Y(12) inhibitors are underutilized. Cost is frequently cited as an explanation for both of these observations....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JAMA
Asıl Yazarlar: Wang, Tracy Y., Kaltenbach, Lisa A., Cannon, Christopher P., Fonarow, Gregg C., Choudhry, Niteesh K., Henry, Timothy D., Cohen, David J., Bhandary, Durgesh, Khan, Naeem D., Anstrom, Kevin J., Peterson, Eric D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Medical Association 2019
Konular:
Original Investigation
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583585/
https://ncbi.nlm.nih.gov/pubmed/30620370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.19791
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller